# BioMarin Pharmaceutical Inc (BMRN) FY2026 Q2 Balance Sheet

- Company: BioMarin Pharmaceutical Inc (BMRN)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001048477-26-000016
- Page: https://plicit.ai/financials/bmrn/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/bmrn-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 11,723,442,000 US dollars
- **Current assets**: 3,971,623,000 US dollars
- **Non-current assets**: 7,751,819,000 US dollars
- **Liabilities**: 5,401,750,000 US dollars
- **Current liabilities**: 1,663,996,000 US dollars
- **Non-current liabilities**: 3,737,754,000 US dollars
- **Equity**: 6,321,692,000 US dollars
- **Inventory**: 1,782,524,000 US dollars
- **Accounts receivable, net**: 1,061,047,000 US dollars
- **Cash and cash equivalents**: 874,005,000 US dollars
- **Other current assets**: 254,047,000 US dollars
- **Short-term investments**: 0 US dollars
- **Intangible assets, net**: 4,879,367,000 US dollars
- **Property, plant and equipment, net**: 989,994,000 US dollars
- **Deferred tax assets**: 888,575,000 US dollars
- **Goodwill**: 655,745,000 US dollars
- **Other assets**: 338,138,000 US dollars
- **Long-term investments**: 0 US dollars
- **Accounts payable and accrued liabilities**: 1,005,793,000 US dollars
- **Current portion of long-term debt, net**: 658,203,000 US dollars
- **Long-term debt, net**: 3,527,939,000 US dollars
- **Other long-term liabilities**: 209,815,000 US dollars
- **Additional paid-in capital**: 6,037,019,000 US dollars
- **Retained earnings**: 304,495,000 US dollars
- **Common stock, $0.001 par value: 500,000,000 shares authorized; 193,535,556 and 192,300,101 shares issued and outstanding, respectively**: 194,000 US dollars
- **Company common stock held by the Nonqualified Deferred Compensation Plan**: negative 11,233,000 US dollars
- **Accumulated other comprehensive loss**: negative 8,783,000 US dollars
- **Gross equity (calculated)**: 6,341,708,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.